Capsules 20 mg, 100 mg, 250 mg
Trade name: temobel.
International nonpropritary name: Temozolomide.
Pharmaceutical form: capsules 20 mg, 100 mg, and 250 mg.
Composition: each capsule contains:
Active ingredients: temozolomide.
Excipients: stearic acid, tartaric acid, colloidal anhydrous silica, sodium starch glycolate type A, anhydrous lactose.
ATC code: L01AX03.
Indications for use
► Adult patients with newly- diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy.
► Children over the age of 3 years and adult patients with malignant glioma, such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy.